By: Samuel Kyobe and Victor Musiime, Makerere University, Uganda
Imagine a mother walking for hours with her sick child, only to find a clinic lacking the tools and treatments. This heartbreaking scenario is a reality for many families in rural Sub-Saharan Africa (SSA), where infectious diseases such as malaria, HIV/AIDS, and tuberculosis persist, accounting for 90% of the global burden. This immense challenge also represents a critical opportunity: research-driven solutions to transform healthcare and save lives.
SUPPORT is an EDCTP3 funded project, is strengthening Africa’s fight against childhood infectious diseases. By building research capacity and training a new generation of African researchers specialising in these diseases, SUPPORT will pave the way for improved treatments for children with HIV and address critical gaps in our understanding of childhood infections.
However, realizing this potential requires overcoming significant obstacles. A complex interplay of factors including infrastructure limitations, cultural factors, ethical and legal issues, and societal implications of research, hinders progress. We must address these challenges head-on to make a real difference.
Despite decades of efforts by governments in SSA with support from development partners through the CDC, USAID, WHO, and the World Bank, these countries continue to grapple with inadequate healthcare systems. For instance, recent data in Uganda indicates that over 70% of the population live more than an hour’s walk from primary healthcare facilities, with access to specialists even more difficult, especially in rural areas where bicycles are only mode of transport.
A critical bottleneck in effective treatment is the lack of accurate diagnostics. While infectious diseases like malaria, pneumonia, and tuberculosis require timely and accurate diagnosis, many SSA clinics lack the necessary laboratory resources, facing both limited funding and a shortage of skilled staff. This often leads to clinical diagnoses made presumptively on signs and symptoms, resulting in unreliable and inaccurate testing and misdiagnosis, which in turn leads to higher treatment costs and poor patient care and adverse outcomes. Clearly, improved diagnostic tools are essential.
Point-of-care (POC) tests are offer a promising solution. These tests, deployed at a patient’s bedside or in “side labs”, drastically reduce diagnostic turnaround times, enabling faster and more efficient treatment.
Projects like SUPPORT are leading the charge in implementing POCs, with the potential to revolutionise healthcare for children living with HIV. By improving diagnostics and monitoring protocols, especially in resource-limited settings, SUPPORT aims to reduce misdiagnosis, ensure appropriate treatment, enable disease detection and most importantly, prevent unnecessary deaths. The project will also have a profound impact on global health, contributing directly to the UN Sustainable Development goal 3: Good Health and Well-being by reducing child mortality. Investing in African research capacity isn’t just about addressing a regional crisis; it’s a global imperative and a crucial step towards a healthier future for all.
